Glaukos

Glaukos

Yahoo Finance • 22 hours ago

iShares Russell 2000 (IWM) Buys $1.9 Million More Jackson Financial on Nov. 2

This article first appeared on GuruFocus. iShares Russell 2000 Index Fund (IWM) recorded a net gain of $285.0 million in Monday's session, part of $287.9 million in gross ETF activity, as it increased 1,880 positions and decreased only 3.... Full story

Yahoo Finance • 3 days ago

Okta Stock Rises Ahead of S&P 500 Entry

This article first appeared on GuruFocus. Okta Inc. (NASDAQ:OKTA) rose 0.36% in premarket after S&P Dow Jones Indices said late Friday the identity and access management provider would join the S&P 500 before the open on November 4. Warn... Full story

Yahoo Finance • 3 days ago

iShares Russell 2000 (IWM) Adds Jackson Financial, Trims Glaukos on Thursday

This article first appeared on GuruFocus. iShares Russell 2000 Index Fund (IWM) posted a one-sided ETF activity day last Thursday, with gross trades of $292.2 million and net selling of $292.1 million against $75.49 billion in assets. The... Full story

Yahoo Finance • 5 days ago

Okta Stock Can Find More Buyers as It Joins the S&P 500

Okta can expect a new pool of buyers for its stock as a member of the S&P 500. Kenvue is being acquired and will therefore depart the index. Continue Reading... Full story

Yahoo Finance • 5 days ago

Okta jumps after-hours following tapped inclusion in the S&P 500

Investing.com -- Okta Inc (NASDAQ:OKTA) shares climbed 2.1% in extended trading Friday after S&P Dow Jones Indices selected the identity and access management provider to join the benchmark S&P 500 index. The after-hours rebound helped the... Full story

Yahoo Finance • 5 days ago

Okta Set to Join S&P 500; Others to Join S&P MidCap 400 and S&P SmallCap 600

NEW YORK, Oct. 30, 2026 /PRNewswire/ -- S&P Dow Jones Indices will make the following changes to the S&P 500, S&P MidCap 400, S&P SmallCap 600 effective prior to the opening of trading on Wednesday, November 4: S&P MidCap 400 constituent... Full story

Yahoo Finance • 7 days ago

Why Glaukos Stock Is Surging 30% and Headed for Record Close After Earnings

Glaukos raises its full-year guidance, triggering a wave of price target hikes across Wall Street. Continue Reading... Full story

Yahoo Finance • 27 days ago

Glaukos' iDose TR meets primary goal in phase 4 trial

[Close-up of mature patient undergoing detailed eye examination with slit lamp and light at ophthalmology clinic] * Glaukos Corp. (GKOS [https://seekingalpha.com/symbol/GKOS]) said that topline phase 4 data for iDose TR (travoprost intr... Full story

Yahoo Finance • 28 days ago

Glaukos slips as insider selling overshadows positive trial data for eye therapy

[An arrow pointing downwards on top of a pile of US dollar bills.] Despite announcing positive data from a late-stage trial for its Epioxa eye therapy, Glaukos Corporation (GKOS [https://seekingalpha.com/symbol/GKOS]) lost more than 13% o... Full story

Yahoo Finance • 2 months ago

Small-cap bears were back. Was IWM the warning sign?

[A stack of coins is shown on a blue background with a world map] IURII KRASILNIKOV The put-call ratio for the iShares Russell 2000 ETF (IWM [https://seekingalpha.com/symbol/IWM]) surged to 3.58, with Barchart saying the reading marked th... Full story

Yahoo Finance • 2 months ago

Ten healthcare stocks leading in year-over-year CapEx growth

[Health Care Medical Stock Market Industry Sector Wall Street Buildings 3d Illustration] iQoncept/iStock via Getty Images With the second-quarter earnings season now largely behind us, investors are turning their attention to how healthca... Full story

Yahoo Finance • 2 months ago

Why Is ISRG Investing More Aggressively in R&D Despite Macro Headwinds?

Intuitive Surgical ISRG is deliberately prioritizing research and development to fuel long-term growth, offsetting near-term challenges from macroeconomic uncertainty, healthcare policy changes and international competitive pressures. In... Full story

Yahoo Finance • 3 months ago

Notable ETF Outflow Detected - SPSM, CORT, GKOS, EAT

Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the SPDR Portfolio S&P 600 Small Cap ETF (Symbol: SPSM) where we have detected an approximate $125.1 million doll... Full story

Yahoo Finance • 3 months ago

Stocks To Watch On Wall Street's Radar — Several In Or Near Buy Range

As the market rallies, Raymond James, Tapestry and U.S. Bancorp lead a slew of stocks to watch in or near buy range. Continue Reading... Full story

Yahoo Finance • 3 months ago

Dow Jones Futures: Stock Market Tumbles, Oil Prices Soar On Trump's Iran Threats; Microsoft, Meta, Fortinet Earnings Late

The stock market sold off as oil prices surged on Trump's Iran threats. Microsoft, Meta and Fortinet were key earnings movers late. Continue Reading... Full story

Yahoo Finance • 3 months ago

Next Century Growth Investors exits Bloom Energy, Coherent; adds DigitalOcean in Q2

[Annual report under review] Willie B. Thomas In its Q2 portfolio update, Next Century Growth Investors disclosed nine new positions across three sectors. The industrial additions were Park Aerospace Corp. (PKE [https://seekingalpha.com/... Full story

Yahoo Finance • 4 months ago

Here Are Monday’s Best Wall Street Analyst Research Calls: Agnico Eagle Mines, Datadog, Delta Air Lines, Gilead Sciences, Okta, Pfizer, Regions Financial, T-Mobile, and More

Quick Read T-Mobile (TMUS) and Gilead Sciences (GILD) both earned Buy upgrades Monday, with Bank of America and HSBC setting targets of $220 and $155 respectively. Pfizer (PFE) and Datadog (DDOG) both took ratings cuts Monday, though Bern... Full story

Yahoo Finance • 8 months ago

Glaukos Announces Commercial Availability of Epioxa™, a Transformative Innovation in Interventional Keratoconus Care

Epioxa Provides the Ophthalmic Community and Patients with the First and Only FDA-Approved, Incision-Free, Topical Drug Therapy for Keratoconus, a Sight-Threatening Rare Disease ALISO VIEJO, Calif., March 19, 2026--(BUSINESS WIRE)--Glauko... Full story

Yahoo Finance • 10 months ago

Here's Why You Should Retain Glaukos Stock in Your Portfolio Now

Glaukos Corporation GKOS is well-poised for growth on the back of the iDose TR launch and a robust product pipeline. However, stiff competition is a concern. Shares of this Zacks Rank #3 (Hold) company have gained 12.5% so far this year c... Full story

Yahoo Finance • 11 months ago

Sudo Biosciences Appoints Paul Bavier as Chief Legal Counsel

CARMEL, Ind. & LONDON, December 04, 2025--(BUSINESS WIRE)--Sudo Biosciences, ("Sudo"), a biopharmaceutical company committed to designing and developing best-in-class precision TYK2 (tyrosine kinase 2) inhibitors, today announced the appoi... Full story